Cutera (NASDAQ:CUTR) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Trading Down 63.9 %

CUTR opened at $0.04 on Thursday. Cutera has a 1-year low of $0.09 and a 1-year high of $3.00. The company has a market cap of $787,254.00, a price-to-earnings ratio of -0.01 and a beta of 1.36. The company’s fifty day moving average price is $0.26 and its two-hundred day moving average price is $0.42.

Institutional Trading of Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP purchased a new stake in Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned about 0.82% of Cutera at the end of the most recent quarter. Institutional investors own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.